These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3199595

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cardiovascular pharmacology of RS-1893, an orally active cardiotonic agent with arterial and venous vasodilator actions.
    Miyake S, Shiga H, Koike H, Mizuno H, Yorikane R, Oda T, Iijima Y, Kumakura S, Morisawa Y.
    Jpn J Pharmacol; 1988 Jul; 47(3):273-83. PubMed ID: 2851676
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of MCI-154, a calcium sensitizer, on left ventricular systolic and diastolic function in pacing-induced heart failure in the dog.
    Teramura S, Yamakado T, Maeda M, Nakano T.
    Circulation; 1997 Feb 04; 95(3):732-9. PubMed ID: 9024164
    [Abstract] [Full Text] [Related]

  • 28. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ, Kruijssen DA, van Hoogenhuyze DC, Krauss XH, Bartels GL, Storm CJ, de Leeuw PW.
    J Cardiovasc Pharmacol; 1994 Nov 04; 24(5):730-9. PubMed ID: 7532750
    [Abstract] [Full Text] [Related]

  • 29. Effects of MCI-154, a new cardiotonic Ca2+ sensitizer, on ventricular arrhythmias and membrane ionic currents.
    Eto K, Xue YX, Hashimoto K.
    Eur J Pharmacol; 1996 Mar 18; 298(3):247-56. PubMed ID: 8846823
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
    Biala A, Martonen E, Kaheinen P, Levijoki J, Finckenberg P, Merasto S, Louhelainen M, Muller DN, Luft FC, Mervaala E.
    Hypertens Res; 2010 Oct 18; 33(10):1004-11. PubMed ID: 20811386
    [Abstract] [Full Text] [Related]

  • 32. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y, Kitada Y, Narimatsu A.
    J Pharmacol Exp Ther; 1993 May 18; 265(2):819-25. PubMed ID: 8496827
    [Abstract] [Full Text] [Related]

  • 33. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC, Roebel LE, Hsieh CP, Weiner DL, Woodward JK.
    J Cardiovasc Pharmacol; 1982 May 18; 4(3):500-8. PubMed ID: 6177949
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog.
    Pastelin G, Mendez R, Kabela E, Farah A.
    Life Sci; 1983 Oct 31; 33(18):1787-96. PubMed ID: 6645777
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.